CHEK1 and neoplasm: For example, phosphorylation of the putative CHK1 Thr 505 (T505) phosphosite in the RelA transactivation domain in vitro results in inhibition of tumour promoting activities of NF-κB, including resistance to apoptosis, autophagy, cell proliferation and cell migration [9–11,17–19].